Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!
Get 25% Off Sitewide on 26th Anniversary Sale Get 25% Off Sitewide on 26th Anniversary Sale

FDA Considers OTC Statin Status For Mevacor

  • December 28, 2004

A little more than a year ago, there was talk in the business press drugmakers Bristol Myers-Squibb and Merck would file separate requests with the FDA to sell their statin drugs, Pravachol and Mevacor respectively, over the counter. That intention has finally become a reality, with Merck's application being considered by an advisory committee Jan. 13-14 and Bristol Myers-Squibb announcing it will seek the same status for Pravachol. Four years ago, Merck's request was denied because...
Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports